Nephrocare Health Services Limited Stock Price Today (NSE: NEPHROPLUS)
Fundamental Score
Nephrocare Health Services Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nephrocare Health Services Limited share price today is ₹735.10, up +0.00% on NSE/BSE as of 17 September 2026. Nephrocare Health Services Limited (NEPHROPLUS) is a Mid-cap company in the Unknown Industry sector with a market capitalisation of ₹7.38K (Cr). The 52-week high for NEPHROPLUS share price is ₹781.50 and the 52-week low is ₹669.00.
Nephrocare Health Services Limited Share Price Chart — NSE/BSE Historical Performance
Nephrocare Health Services Limited share price chart: 5.59% return over the past month. 52-week high ₹781.50, 52-week low ₹669.00.
Nephrocare Health Services Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹734.85 | ₹742.70 | ₹710.05 | ₹735.20 | 1.44L (Cr) | |
| ₹770.00 | ₹774.95 | ₹725.00 | ₹734.95 | 3.06L (Cr) | |
| ₹747.25 | ₹781.50 | ₹734.05 | ₹765.35 | 3.37L (Cr) | |
| ₹733.10 | ₹751.15 | ₹731.05 | ₹747.25 | 2.05L (Cr) | |
| ₹744.10 | ₹757.70 | ₹725.75 | ₹733.45 | 2.04L (Cr) | |
| ₹713.00 | ₹748.60 | ₹707.10 | ₹744.10 | 6.59L (Cr) | |
| ₹704.90 | ₹715.70 | ₹697.55 | ₹710.85 | 1.89L (Cr) | |
| ₹711.85 | ₹720.00 | ₹692.00 | ₹697.05 | 1.98L (Cr) | |
| ₹693.30 | ₹712.30 | ₹686.10 | ₹706.75 | 1.98L (Cr) | |
| ₹695.00 | ₹699.25 | ₹677.60 | ₹692.70 | 1.69L (Cr) |
Nephrocare Health Services Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹701.00 | ₹781.50 | ₹677.60 | ₹735.20 | +4.88% | |
| ₹702.20 | ₹714.05 | ₹669.00 | ₹682.95 | -2.74% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nephrocare Health Services Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nephrocare Health Services Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEPHROPLUS across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 2.80)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (63.85%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 76.18x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (6.61x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Nephrocare Health Services Limited vs Sector Peers
Nephrocare Health Services Limited Quarterly Performance
Latest quarterly metrics for NEPHROPLUS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Nephrocare Health Services Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NEPHROPLUS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nephrocare Health Services Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nephrocare Health Services Limited (NEPHROPLUS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Nephrocare Health Services Limited
About NEPHROPLUS (Nephrocare Health Services Limited)
Nephrocare Health Services Limited (NEPHROPLUS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Unknown Industr...y sector with a current market capitalisation of ₹7.38K (Cr). The debt-to-equity ratio stands at 0.07, reflecting the company's capital structure. Investors tracking NEPHROPLUS share price can monitor key metrics including P/E ratio, promoter holding of 63.85%, and quarterly earnings growth.
Company Details
NEPHROPLUS Share Price: Frequently Asked Questions
What is the current share price of Nephrocare Health Services Limited?
Nephrocare Health Services Limited (NEPHROPLUS) trades at ₹735.10 on NSE. Market cap ₹7.38K (Cr). Educational data only.
What is the P/E ratio of Nephrocare Health Services Limited?
Nephrocare Health Services Limited has a P/E of 76.18x vs industry average N/Ax.
What is the Bull Run score for Nephrocare Health Services Limited?
Nephrocare Health Services Limited has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Nephrocare Health Services Limited pay dividends?
Nephrocare Health Services Limited has a dividend yield of N/A. Past dividends don't guarantee future payments.
What is the ROE of Nephrocare Health Services Limited?
Nephrocare Health Services Limited has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nephrocare Health Services Limited?
Nephrocare Health Services Limited has debt-to-equity of 0.07.
Is Nephrocare Health Services Limited a good investment?
Bull Run gives Nephrocare Health Services Limited a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.